A collaborative approach to advising health care and life sciences clients worldwide earned Ropes & Gray honors as The American Lawyer 2024 Industry Awards Corporate Practice of the Year in the Pharma and Health Care category. The firm previously received the award in 2022. The award recognizes a firm that is leading impactful and innovative legal work in healthcare and pharmaceuticals.
An American Lawyer profile article noted that Ropes & Gray has advised on transformative “mega deals” in the healthcare and life sciences sectors and guided 1Life Healthcare, Inc. (One Medical) in its $3.9 billion sale to Amazon, Signify Health in its $8 billion sale to CVS. The firm also advised Pfizer in its $11.6 billion acquisition of Biohaven Pharmaceuticals and Immunogen in its $10.1 billion sale to AbbVie.
Additionally, the firm was recognized for facilitating over 110 complex licensing and collaboration deals, with a total value of $55 billion, including several top biopharmaceutical licensing deals in 2023.
The article includes comments from health care partner and practice co-chair Tim McCrystal, life sciences mergers & acquisitions partner Michael Beauvais and IP transactions partner and practice co-chair Melissa Rones.
"The entire ecosystem that makes the life sciences and health care industry operate, we're doing work throughout it, including these tremendously large deals and these transformative transactions that really do set companies and technologies in different directions," said Melissa.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.